Sai Life Sciences Ltd

Stage 2 · Advancing · week 32Setup 5.4 ★ FairStrong +5.8

As of 9 Oct 2026, Sai Life Sciences is in Stage 2 — advancing, the uptrend phase, in week 32 (since 23 Feb 2026). It closed at ₹1,488, 11.2% below its 52-week high and above its 200-day average, which is rising. In Health Care, 44.6% of stocks are in Stage 2.

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. More about the company

₹1,487.9
-1.18% today
₹31,606 Cr · Large cap
Market Neutral — FadingHealth Care 44.6% in Stage 2-2.6 pts / 20dBiotechnology 22.2%-11.1 pts

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

5.4 ★ Fair

Momentum

Steady

Edge

Strong +5.8

Setup-score rank among Stage 2 peers: #1 of 2 in Biotechnology · #29 of 78 in Health Care

Is SAILIFE early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-11.2%
₹795 lo₹1,675.4 hi
11.2% below 52W high — pullback range
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 32
1w13w26w
Week 32 — mature, watch for distribution
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
28.4%
200 DMA: ₹1,159.1 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.64x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -0.6% vs MA50 +8.7%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-9.7%
3M
+17.6%
6M
+52.8%
YTD
+65.0%
1Y
+67.7%
Sector
Health Care
↓ Peaking
Stage 2%
44.6%
20d Δ
-2.6pp
1M return
-4.9%
3M return
+0.2%
Sector Stage-2 % · last 20 days
This stock ranks #13 of 74 Stage 2 stocks in Health Care by RS.
Industry
Biotechnology
↓ Peaking
Stage 2%
22.2%
20d Δ
-11.1pp
1M return
-8.7%
3M return
-0.7%
Industry Stage-2 % · last 20 days
Ranks #1 of 2 Stage 2 stocks in this industry. Top stock in industry.
Stage Cycle Timeline2024-12-18 → 2026-10-09
S? 42w
S2 16w
S2 33w
2024-12-182026-10-09
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S2 16w → S3 3w → S2 33w current
Total tracked: 94 weeks across 4 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-02-23
2 appearances in last 60 days. First seen: 2025-10-07.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-09S2
Wk 32 · Vol 0.64x
2026-10-08S2
Wk 32 · Vol 0.77x
2026-10-07S2
Wk 32 · Vol 0.99x
2026-10-06S2
Wk 32 · Vol 0.42x
2026-10-05S2
Wk 32 · Vol 0.49x
2026-10-01S2
Wk 31 · Vol 0.89x
2026-09-30S2
Wk 31 · Vol 0.82x
2026-09-29S2
Wk 31 · Vol 0.55x
2026-09-28S2
Wk 31 · Vol 0.42x
2026-09-25S2
Wk 31 · Vol 0.40x
2026-09-24S2
Wk 30 · Vol 0.80x
2026-09-23S2
Wk 30 · Vol 0.41x
Sector Peers — Stage 2All →
BAFNAPH
wk 18 · 0.0% from hi
8.6
ZIMLAB
wk 22 · 0.0% from hi
8.3
KILITCH
wk 2 · -7.3% from hi
8.3
SMSPHARMA
wk 3 · -8.0% from hi
8.3
RPGLIFE
wk 16 · -12.0% from hi
7.6
Moving averages & range
50 DMA
₹1,502.8
200 DMA
₹1,159.1
52W High
₹1,675.4
52W Low
₹795
5D Low
₹1,487.9
Resistance levels (recent highs)
20d High
₹1,610.1
60d High
₹1,675.4
120d High
₹1,675.4
250d High
₹1,675.4
Next resistance
+8.2%
to 20d High
Ask the Market AI about SAILIFEAsk →
P/E (TTM)
68.8
Forward 46.1
Earnings Growth (YoY)
+17.6%
Revenue +3.9%
ROE
+15.1%
Profit margin +15.9%
About this companyHealth Care· Biotechnology

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-09. Past data patterns are not indicative of future results. This page is a data analytics tool only.